A new humanized antibody is effective against pathogenic fungi in vitro
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new humanized antibody is effective against pathogenic fungi in vitro
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-30
DOI
10.1038/s41598-021-98659-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in the relative prevalence of candidemia due to non‐ albicans Candida species in adult in‐patients: a systematic review, meta‐analysis, and meta‐regression
- (2020) Daniele Roberto Giacobbe et al. MYCOSES
- Drug resistance and tolerance in fungi
- (2020) Judith Berman et al. NATURE REVIEWS MICROBIOLOGY
- Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
- (2020) Faustino et al. Pharmaceutics
- Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
- (2020) Sofia Costa-de-Oliveira et al. Microorganisms
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
- (2019) Tomas Di Mambro et al. Frontiers in Pharmacology
- Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence
- (2019) B. Short et al. JOURNAL OF HOSPITAL INFECTION
- The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
- (2019) Shakti Singh et al. PLoS Pathogens
- Antibodies to watch in 2018
- (2018) Hélène Kaplon et al. mAbs
- Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control – An update
- (2018) Maryam Dadar et al. MICROBIAL PATHOGENESIS
- Humanization of Antibodies using a Statistical Inference Approach
- (2018) Alejandro Clavero-Álvarez et al. Scientific Reports
- Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis
- (2018) Fiona M. Rudkin et al. Nature Communications
- Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?
- (2018) Luana Rossato et al. Frontiers in Microbiology
- Immunotherapeutic approaches to treatment of fungal diseases
- (2017) Darius Armstrong-James et al. LANCET INFECTIOUS DISEASES
- The global problem of antifungal resistance: prevalence, mechanisms, and management
- (2017) David S Perlin et al. LANCET INFECTIOUS DISEASES
- The antifungal pipeline: a reality check
- (2017) John R. Perfect NATURE REVIEWS DRUG DISCOVERY
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe
- (2016) Tinashe K. Nyazika et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination
- (2016) Di Chen et al. Molecular BioSystems
- Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species
- (2015) Natasha Whibley et al. CYTOKINE
- Cryptococcus neoformans–Induced Macrophage Lysosome Damage Crucially Contributes to Fungal Virulence
- (2015) Michael J. Davis et al. JOURNAL OF IMMUNOLOGY
- The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
- (2015) Pietro Sormanni et al. JOURNAL OF MOLECULAR BIOLOGY
- The present state of the art in expression, production and characterization of monoclonal antibodies
- (2015) Christopher L. Gaughan MOLECULAR DIVERSITY
- Honey flavonoids inhibit Candida albicans morphogenesis by affecting DNA behavior and mitochondrial function
- (2014) Barbara Canonico et al. Future Microbiology
- Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
- (2013) Francesca Bugli et al. Clinical & Developmental Immunology
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant
- (2012) Emily W. Bratton et al. PLoS One
- Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapy
- (2009) Paul Dent et al. DRUG RESISTANCE UPDATES
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
- (2009) Kazuo Satoh et al. MICROBIOLOGY AND IMMUNOLOGY
- Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
- (2009) Antonella Torosantucci et al. PLoS One
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Discovery of a Small-Molecule Inhibitor of -1,6-Glucan Synthesis
- (2008) A. Kitamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now